The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on at the influence and intersection of sex and gender in health and disease including: (1) research proposals that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five research priorities in the new 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered through by NIH ICs using funds that have been made

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention. Applications may propose treatment or prevention products delivered using sustained release platforms (oral, injection, implant or direct delivery to HIV target mucosa) that will provide a minimum of 1 week for oral (treatment) or a minimum of once a month for all other drug delivery systems for prevention and treatment.

Notice Special Interest: Promoting research opportunities HIV/AIDS NIAMS Notice Number: NOT-AR-20-005 Key Dates Release Date: October 22, 2019 First Available Due Date: December 02, 2019 Expiration Date: January 08, 2022 Related Announcements PA-19-056: NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-053: NIH Exploratory/Developmental Research Grant Program Parent R21 Clinical Trial Allowed) RFA-AR-20-001: Mechanistic Ancillary Studies Ongoing Clinical Projects R01 Clinical Trial Allowed) RFA-AR-20-002: Mechanistic Ancillary Studies Ongoing Clinical Projects R21 Clinical

The purpose of this Funding Opportunity Announcement (FOA) is to support grants to improve understanding of viral suppression and HIV transmission in the United States (U.S.) using population-level epidemiology, novel tools from data science approaches and m/eHealth, and implementation science research. Data generated through this research will be used to inform and evaluate context-specific HIV control strategies towards the goal of ending the HIV epidemic in the U.S.

This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer.
Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus
[HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (pathogenic or nonpathogenic)

The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US.

Notice Special Interest NOSI): of Biological High" Medium" Priority AIDS Research Non-AIDS-defining AIDS-defining Cancers Notice Number: NOT-CA-20-022 Key Dates Release Date: January 15, 2020 First Available Due Date: 07, 2020 Expiration Date: January 08, 2023 Related Announcements PA-19-056 NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-053 NIH Exploratory/Developmental Research Grant Program Parent R21 Clinical Trial Allowed) PAR-20-052 NCI Small Grants Program Cancer Research Years 2020, 2021, 2022 NCI Omnibus R03 Clinical Trial Optional) PAR-20-030 HIV-ass

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of high-priority, regionally relevant infectious disease research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Eligibility status of applicant organizations will be determined by this World Bank Classification list at application submission date.

Notice Special Interest NOSI): Transcriptomic, epigenomic, regulatory RNA functional genomic research Substance Disorders Notice Number: NOT-DA-20-031 Key Dates Release Date: February 6, 2020 First Available Due Date: June 5, 2020 Expiration Date: January 8, 2023 Related Announcements PA-19-056: NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-091: NIH Research Project Grant Parent R01 Basic Experimental Studies Humans Required) PA-19-052: NIH Small Research Grant Program Parent R03 Clinical Trial Allowed) PA-19-053: NIH Exploratory/Developmental Research Grant Program Pa

Notice Special Interest NOSI): Drug-drug interactions among substances abuse, medications treat HIV infection, pharmacotherapies treat substance disorders Notice Number: NOT-DA-20-013 Key Dates Release Date: February 6, 2020 First Available Due Date: 7, 2020 Expiration Date: 8, 2022 Related Announcements PA-19-056: NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-055: NIH Research Project Grant Parent R01 Clinical Trial Required) PA-19-091: NIH Research Project Grant Parent R01 Basic Experimental Studies Humans Required) PA-19-052: NIH Small Research Grant Program Parent